Skip to main content
Premium Trial:

Request an Annual Quote

Sounds Promising, But We're Not Sold Yet

Michael Leavitt, secretary of the US Department of Health and Human Services, recently released a report (PDF here) on the state of personalized healthcare in America. In response, Rick Weiss at Science Progress has a thoughtful post about the concept of personalized medicine -- and the associated costs in implementing such a program. Based on the HHS report, he writes, "one can't help but conclude ... that it is going to be an uphill battle to justify some of the upfront costs of the personalized medicine revolution, given the many technical, political, and educational hurdles that stand between where we are and where we want to get." He describes a number of those hurdles -- electronic health records, physician education, privacy protection, and more -- but doesn't mince words about the current system: "Some kind of reform is clearly needed," he writes.


The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.